{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:38:03Z","timestamp":1761561483558},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.dld.2010.09.009","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T04:41:55Z","timestamp":1288845715000},"page":"209-214","source":"Crossref","is-referenced-by-count":11,"title":["Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs"],"prefix":"10.1016","volume":"43","author":[{"given":"G\u00e9rard","family":"Thi\u00e9fin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Sophie","family":"Schwalm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2010.09.009_bib0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/07853890600925843","article-title":"Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies","volume":"38","author":"Lanas","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004836-198904000-00009","article-title":"Dyspepsia in NSAID users: the size of the problem","volume":"11","author":"Larkai","year":"1989","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 56","key":"10.1016\/j.dld.2010.09.009_bib0015","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"26","author":"Singh","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dld.2010.09.009_bib0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.09.009_bib0025","first-page":"CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","volume":"4","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2010.09.009_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.09.009_bib0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1046\/j.1365-2036.2003.01762.x","article-title":"Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in non-steroidal anti-inflammatory drug users \u2013 a randomized trial","volume":"18","author":"Lai","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0050","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0055","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","article-title":"Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications","volume":"118","author":"Lai","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0060","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.09.009_bib0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.2004.02078.x","article-title":"Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract","volume":"20","author":"Lanas","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0070","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. An overview of epidemiologic studies published in the 1990s","volume":"160","author":"Hernandez-Diaz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.46.1.27","article-title":"Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs","volume":"46","author":"Weil","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.09.009_bib0080","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.09.009_bib0085","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","article-title":"Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis","volume":"123","author":"Laine","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.09.009_bib0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0016-5085(99)70494-4","article-title":"Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study","volume":"116","author":"Aalykke","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.09.009_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00365529609031975","article-title":"Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision making","volume":"31","author":"Hansen","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.09.009_bib0100","first-page":"133","article-title":"Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice","volume":"55","author":"Moore","year":"2000","journal-title":"Therapie"},{"key":"10.1016\/j.dld.2010.09.009_bib0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00228-001-0378-5","article-title":"Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France","volume":"57","author":"Clinard","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dld.2010.09.009_bib0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pds.623","article-title":"Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitoner-based survey and a pharmacy-based survey in France","volume":"10","author":"Clinard","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.dld.2010.09.009_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2515\/therapie:2006029","article-title":"Patterns of non steroidal anti-inflammatory drug use in ambulatory care","volume":"61","author":"Lugardon","year":"2006","journal-title":"Therapie"},{"issue":"Suppl 3","key":"10.1016\/j.dld.2010.09.009_bib0120","first-page":"iii23","article-title":"Underutilization of preventive strategies in patients receiving NSAIDs","volume":"42","author":"Sturkenboom","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.dld.2010.09.009_bib0125","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0149-2918(01)80151-X","article-title":"Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database","volume":"23","author":"Schnitzer","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0130","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/art.10425","article-title":"Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs","volume":"46","author":"Smalley","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2010.09.009_bib0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.amjopharm.2004.09.001","article-title":"Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada","volume":"2","author":"Hartnell","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.dld.2010.09.009_bib0140","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","article-title":"National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs","volume":"129","author":"Abraham","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.09.009_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2036.2005.02537.x","article-title":"Upper gastrointestinal symptoms and therapies in elderly outpatients, users of non-selective NSAIDs or coxibs","volume":"22","author":"Pilotto","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0150","unstructured":"Recommandations de bonne pratique. Les anti-s\u00e9cr\u00e9toires gastriques chez l\u2019adulte. 2007. Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9. www.afssaps.fr [accessed 19.01.10]."},{"key":"10.1016\/j.dld.2010.09.009_bib0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1365-2036.2006.03173.x","article-title":"Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general population","volume":"24","author":"Rey","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0160","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1572-0241.1998.00588.x","article-title":"A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Lanza","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.09.009_bib0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01795.x","article-title":"Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs","volume":"18","author":"Sturkenboom","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.09.009_bib0170","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","article-title":"Impact of adherence to concomitant gastroprotective therapy of nonsteroidal-related gastroduodenal ulcer complications","volume":"4","author":"Goldstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.09.009_bib0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2007.03358.x","article-title":"Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and hemorrhage","volume":"26","author":"van Soest","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"issue":"Suppl 3","key":"10.1016\/j.dld.2010.09.009_bib0180","first-page":"A28","article-title":"A new safety warning: decreased gastroprotection is associated with an increase of serious ulcer complications in elderly users of NSAIDs","volume":"56","author":"Singh","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.09.009_bib0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1472-8206.2007.00489.x","article-title":"Coxibs: evolution of prescription's behaviour in France","volume":"21","author":"Biga","year":"2007","journal-title":"Fund Clin Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.dld.2010.09.009_bib0190","first-page":"A230","article-title":"Prevalence of low-dose aspirin treatment in France and concomitant use of gastrotoxic and gastroprotective agents: results of a nation-wide postal survey","volume":"56","author":"Thi\u00e9fin","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.09.009_bib0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2010.09.009_bib0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/ard.2003.015925","article-title":"Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach","volume":"63","author":"Richy","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2010.09.009_bib0205","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.amjmed.2005.11.020","article-title":"Comparing rates of dyspepsia with coxibs vs NSAID+PPI: a meta-analysis","volume":"119","author":"Spiegel","year":"2006","journal-title":"Am J Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581000318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581000318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T21:22:11Z","timestamp":1544131331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581000318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S159086581000318X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2010.09.009","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}